Opioid systems and the newborn

British Journal of Anaesthesia

Volumn 79, Issue 6, 1997, Pages 787-795

  Marsh, D F ^a,b   Hatch, D J ^a   Fitzgerald, M ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Analgesics opioid; Model, rat; Neonates

Indexed keywords

ALFENTANIL; CODEINE; DIAMORPHINE; FENTANYL; MORPHINE; OPIATE; OPIATE RECEPTOR; SUFENTANIL;

CENTRAL NERVOUS SYSTEM; HUMAN; NEUROBIOLOGY; NEWBORN; ONTOGENY; PAIN; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW;

EID: 0030827657     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/79.6.787     Document Type: Review

References (86)

1. Abbott FV, Guy ER. Effects of morphine, pentobarbital and amphetamine on formalin-induced behaviours in infant rats: sedation versus specific suppression of pain. Pain 1995; 62: 303-312.
2. Arnold JH, Troug RD, Scavone JM, Fenton T. Changes in the pharmacodynamic response to fentanyl in neonates during continuous infusion. Pediatric Pharmacology and Therapeutics 1991; 119: 639-643.
3. Attali B, Saya D, Vogel Z. Pre- and postnatal development of opiate receptor subtypes in rat spinal cord. Developmental Brain Research 1990; 53: 97-102.
4. Barr G, Paredes W, Erikson KL, Zukin SR. κ opioid receptor-mediated analgesia in the developing rat. Developmental Brain Research 1986; 29: 145-152.
5. Basbaum AI. Insights into the development of opioid tolerance. Pain 1995; 61: 349-352.
6. Bayon A, Shoemaker WJ, Bloom FE, Mauss A, Guillemin R. Perinatal development of the endorphin- and enkephalin-containing systems in the rat brain. Brain Research 1979; 179: 93-101.
7. Besse D, Lombard MC, Zajac JM, Roques BP, Besson JM. Pre- and postsynaptic distribution of μ, δ and κ opioid receptors in the superficial layers of the cervical dorsal horn of the rat spinal cord. Brain Research 1990; 521: 15-22.
8. Besson JM, Chaouch A. Peripheral and spinal mechanisms of nociception. Physiological Reviews 1987; 67: 67-186.
9. Boerner U, Abbott S, Roe RL. The metabolism of morphine and heroin in man. Drug Metabolism Reviews 1975; 4: 39-73.
10. Charnay Y, Paulin C, Dray F, Dubois P-M. Distribution of enkephalin in the human fetus and spinal cord: an immunofluorescence study. Journal of Comparative Neurology 1984; 223: 415-423.
11. Chay PCW, Duffy BJ, Walker JS. Pharmacokinetic-pharmacodynamic relationships of morphine in neonates. Clinical Pharmacology and Therapeutics 1992; 51: 334-342.
12. Dalsgaard J, Felsby S, Juelsgaard P, Froekjaer J. Low-dose intra-articular morphine analgesia in day case knee arthroscopy: a randomized double-blinded prospective study. Pain 1994; 56: 151-154.
13. De Lima J, Lloyd-Thomas AR, Howard RF, Sumner E, Quinn TM. Infant and neonatal pain: anaesthetists' perceptions and prescribing patterns. British Medical Journal 1996; 313: 787.
14. Dickenson AH. Spinal cord pharmacology of pain. British Journal of Anaesthesia 1995; 75: 193-200.
15. Dickenson AH. Where and how do opioids act? In: Gebhart GF, Hammond DL, Jensen TS, eds. Proceedings of the 7th World Conference on Pain, Progress in Pain Research and Management. Seattle: IASP Press, 1994; 525-552.
16. Elias-Jones AC, Barrett DA, Rutter N, Shaw PN, Davis SS. Diamorphine infusion in the preterm neonate. Archives of Disease in Childhood 1991; 66: 1155-1157.
17. Fitzgerald M. Pain in infancy: some unanswered questions. Pain Reviews 1995; 2: 77-91.
18. Fitzgerald M. The developmental neurobiology of pain. In: Bond MR, Charlton JE, Woolf CJ, eds. Proceedings of the 6th World Congress on Pain, Pain Research and Clinical Management. Amsterdam: Elsevier, 1991; 253-262.
19. Fitzgerald M, Anand KJS. Developmental neuroanatomy and neurophysiology of pain. In: Schechter NL, Berde CB, Yaster M, eds. Pain in Infants, Children and Adolescents. Baltimore: Williams and Wilkins, 1993; 11-31.
20. Fitzgerald M, Butcher T, Shortland P. Developmental changes in the laminar termination of A fibre cutaneous sensory afferents in the rat spinal cord dorsal horn. Journal of Comparative Neurology 1994; 348: 225-233.
21. Fitzgerald M, Koltzenburg M. The functional development of descending inhibitory pathways in the dorsolateral funiculus of the newborn rat spinal cord. Developmental Brain Research 1986; 24: 261-270.
22. Giordano J, Barr GA. Morphine- and ketocyclazocine-induced analgesia in the developing rat: differences due to type of noxious stimulus and body topography. Developmental Brain Research 1987; 32: 247-253.
23. Greeley WJ, de Bruijn NP, Davis DP. Sufentanil pharmacokinetics in pediatric cardiovascular patients. Anesthesia and Analgesia 1987; 66: 1067-1072.
24. Hand CW, Blunnie WP, Claffey LP, McShane AJ, McQuay HJ, Moore RA. Potential analgesic contribution from morphine-6-glucuronide in CSF. Lancet 1987; 2: 1207-1208.
25. Hanna MH, Peat SJ, Woodham M, Knibb A, Fung C. Analgesic efficacy and CSF pharmacokinetics of intrathecal morphine-6-glucuronide: comparison with morphine. British Journal of Anaesthesia 1990; 64: 547-550.
26. Hartley R, Green M, Quinn M, Levene MI. Pharmacokinetics of morphine infusion in premature neonates. Archives of Disease in Childhood 1993; 69: 55-58.
27. Hartley R, Green M, Quinn MW, Rushforth JA, Levene MI. Development of morphine glucuronidation in premature neonates. Biology of the Neonate 1994; 66: 1-9.
28. Hartley R, Levene MI. Opioid pharmacology in the newborn. In: Aynsley-Green A, Ward-Platt MP, Lloyd-Thomas AR, eds. Stress and Pain in Infancy and Childhood. London: Baillière Tindall, 1995; 467-493.
29. Hauser KF, McLaughlin PJ, Zagon IS. Endogenous opioids regulate dendritic growth and spine formation in developing rat brain. Brain Research 1987; 416: 157-161.
30. Hauser KF, McLaughlin PJ, Zagon IS. Endogenous opioid systems and the regulation of dendritic growth and spine formation. Journal of Comparative Neurology 1989; 281: 13-22.
31. Heine MF, Tillet ED, Tsueda K, Loyd GE, Schroeder JA, Vogel RL, Yli-Hankala A. Intra-articular morphine after arthroscopic knee operation. British Journal of Anaesthesia 1994; 73: 413-415.
32. Hori Y, Endo K, Takahashi T. Presynaptic inhibitory action of enkephalin on excitatory transmission in superficial dorsal horn of rat spinal cord. Journal of Physiology (London) 1992; 450: 673-685.
33. Hughes I, Smith TW, Kosterlitz HW, Fothergill FA, Morgan BA, Morris HR. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature (London) 1975; 258: 577-579.
34. Jennings E, Fitzgerald M. C-fos can be induced in the neonatal rat spinal cord by both noxious and innocuous peripheral stimulation. Pain 1996; 68: 301-306.
35. Jennings E, Fitzgerald M. Postnatal changes in A fibre evoked responses in rat dorsal cord. IASP 8th World Congress on Pain, 1996; abstract.
36. 6] enkephalin and naltrindole 5-isothiocyanate: evidence for delta receptor subtypes. Journal of Pharmacology and Experimental Therapeutics 1991; 257:1069-1075.
37. Kanjhan R. Opioids and pain. Clinical and Experimental Pharmacology and Physiology 1995; 22: 397-403.
38. Kar S, Quirion R. Neuropeptide receptors in developing and adult rat spinal cord: an in vitro quantitative autoradiography study of calcitonin gene-related peptide, neurokinins, μ-opioid, galanin, somatostatin, neurotensin and vasoactive intestinal polypeptide receptors. Journal of Comparative Neurology 1995; 354: 253-281.
39. Koren G, Butt W, Chinyanga H, Soldin S, Tan Y-K, Pape K. Postoperative morphine infusion in newborn infants: assessment of disposition characteristics and safety. Journal of Pediatrics 1985; 107: 963-967.
40. Kornblum HI, Loughlin SE, Leslie FM. Effects of morphine on DNA synthesis in neonatal rat brain. Developmental Brain Research 1987; 31: 45-52.
41. Kosterlitz HW. Opioid peptides and their receptors. Proceedings of the Royal Society of London 1985; B225: 27-40.
42. Kupferberg HJ, Way EL. Pharmacological basis for the increased sensitivity of the newborn rat to morphine. Journal of Pharmacology and Experimental Therapeutics 1963; 141: 105-112.
43. Lawrence AJ, Michalkiewicz A, Morley JS, MacKinnon K, Billington D. Differential inhibition of hepatic morphine UDP-glucuronosyltransferases by metal ions. Biochemical Pharmacology 1992; 43: 2335-2340.
44. Lazorthes Y, Verdie JC, Caute B, Maranhao R, Tafani M. Intracerebroventricular morphinotherapy for control of cancer pain. Progress in Brain Research 1988; 77: 395-405.
45. Leslie FM, Tso S, Hurlbut DE. Differential appearance of opiate receptor subtypes in neonatal rat brain. Life Sciences 1982; 31: 1393-1396.
46. Lockridge O, Mottershaw-Jackson N, Eckerson HW, La Du BN. Hydrolysis of diacetylmorphine (heroin) by human serum cholinesterase. Journal of Pharmacology and Experimental Therapeutics 1980; 215: 1-8.
47. Lombard M-C, Besson JM. Attempts to gauge the relative importance of presynaptic and postsynaptic effects of morphine on the transmission of noxious messages in the dorsal horn of the rat spinal cord. Pain 1989; 37: 335-345.
48. Lynn AM, Nespeca MK, Opheim KE, Slattery JT. Respiratory effects of intravenous morphine infusions in neonates, infants, and children after cardiac surgery. Anesthesia and Analgesia 1993; 77: 695-701.
49. Mackenzie PI, Haque SJ. Multiplicity and structure of UDP-glucuronosyltransferase as revealed by gene cloning. In: Miners JO, Birkett DJ, Drew R. May BK, McManus ME, eds. Microsomes and Drug Oxidation. London: Taylor and Francis, 1988; 271-278.
50. Mansour A, Watson SJ. Anatomical distribution of opioid receptors in mammalians: an overview. In: Hertz A., ed. Opioids I. Berlin: Springer-Verlag, 1993; 79-106.
51. Mao J, Price DD, Mayer DJ. Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain 1995; 61: 353-364.
52. Marlow N, Weindling AM, Cooke RWI. Hazards of analgesia for newborn infants. Archives of Disease in Childhood 1988; 63: 1293.
53. Marlow N, Weindling AM, Van Peer A, Heykants J. Alfentanil pharmacokinetics in preterm infants. Archives of Disease in Childhood 1990; 65: 349-351.
54. Mather LE. Clinical pharmacokinetics of fentanyl and its newer derivatives. Clinical Pharmacokinetics 1983; 8: 422-446.
55. McLaughlin CR, Lichtman AH, Fanselow MS, Cramer CP. Tonic nociception in neonatal rats. Pharmacology, Biochemistry and Behavior 1990; 36: 859-862.
56. Pasternak GW. Pharmacological mechanisms of opioid analgesics. Clinical Neuropharmacology 1993; 16: 1-18.
57. Paul D, Standifer KM, Inturrisi CE, Pasternak GW. Pharmacological characterization of morphine-6β-glucuronide, a very potent morphine metabolite. Journal of Pharmacology and Experimental Therapeutics 1989; 251: 477-483.
58. Pert CB, Snyder SH. Opiate receptor: demonstration in nervous tissue. Science 1973; 179: 1011-1014.
59. Pickel VM, Sumal KK, Miller RJ. Early prenatal development of substance P and enkephalin-containing neurons in the rat. Journal of Comparative Neurology 1982; 210: 411-422.
60. Pokela M-J, Ryhänen PT, Koivisto ME, Olkkola KT, Saukkonen A-L. Alfentanil-induced rigidity in newborn infants. Anesthesia and Analgesia 1992; 75: 252-257.
61. Purcell-Jones G, Dorman F, Sumner E. The use of opioids in neonates. A retrospective study of 933 cases. Anaesthesia 1987; 42: 1316-1320.
62. Purcell-Jones G, Dorman F, Sumner E. Paediatric anaesthetists' perceptions of neonatal and infant pain. Pain 1988; 33: 181-187.
63. Quiding H, Anderson P, Bondesson U, Boreus LO, Hynning PÅ. Plasma concentrations of codeine and its metabolite, morphine, after single and repeated oral administration. European Journal of Clinical Pharmacology 1986; 30: 673-677.
64. Quiding H, Olsson GL, Boreus LO, Bondesson U. Infants and young children metabolise codeine to morphine. A study after single and repeated rectal administration. British Journal of Clinical Pharmacology 1992; 33: 45-49.
65. Reisine T, Bell GI. Molecular biology of opioid receptors. Trends in Neurosciences 1993; 16: 506-510.
66. Roth B, Schlünder C, Houben F, Günther M, Theisohn M. Analgesia and sedation in neonatal intensive care using fentanyl by continuous infusion. Developmental Pharmacology and Therapeutics 1991; 17: 121-127.
67. Rius RA, Barg J, Bem WT, Coscia CJ, Loh YP. The prenatal developmental profile of expression of opioid peptides and receptors in the mouse brain. Developmental Brain Research 1991; 58: 237-241.
68. Shanahan EC, Marshall AG, Garrert CPO. Adverse reactions to intravenous codeine phosphate in children. Anaesthesia 1983; 38: 40-43.
69. 3H]etorphine to rat-brain homogenate. Proceedings of the National Academy of Science USA 1973; 70: 1947-1949.
70. Smith MT, Watt JA, Cramond T. Morphine-3-glucuronide - a potent antagonist of morphine analgesia. Life Sciences 1990; 47: 579-585.
71. Stein C. Peripheral mechanisms of opioid analgesia. Anesthesia and Analgesia 1993; 76: 182-191.
72. Stein C. The control of pain in peripheral tissue by opioids. New England Journal of Medicine 1995; 332: 1685-1690.
73. Stein C, Millan MJ, Shippenberg TS, Peter K, Herz A. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. Journal of Pharmacology and Experimental Therapeutics 1989; 248: 1269-1275.
74. Stiene-Martin A, Hauser KF. Opioid-dependant growth of glial cultures: suppression of astrocyte DNA synthesis by met-enkephalin. Life Sciences 1990; 46: 91-98.
75. Tempel A. Visualization of mu opiate receptor downregulation following morphine treatment in neonatal rat brain. Developmental Brain Research 1991; 64: 19-26.
76. Tempel A, Habas JE, Paredes W, Barr GA. Morphine induced downregulation of μ-opioid receptors in neonatal rat brain. Developmental Brain Research 1988; 41: 129-133.
77. Terenius I. Characteristics of the "receptor" for narcotic analgesics in synaptic plasma membrane fraction from rat brain. Acta Pharmacologica et Toxicologica 1973; 33: 377-384.
78. Uhl GR, Childers S, Pasternak G. An opiate-receptor gene family reunion. Trends in Neurosciences 1994; 17: 89-93.
79. Van Praag H, Frenk H. The development of stimulation produced-analgesia (SPA) in the rat. Developmental Brain Research 1991; 64: 71-76.
80. Van Praag H, Frenk H. The effects of systemic morphine on behaviour and EEG in newborn rats. Developmental Brain Research 1992; 67: 19-26.
81. 5-enkephalinamide treatment on the DNA synthesis in the developing rat brain. Life Sciences 1982; 31: 119-126.
82. Way EL, Kemp JW, Young JM, Grassetti DR. The pharmacological effects of heroin in relationship to its rate of biotransformation. Journal of Pharmacology and Experimental Therapeutics 1960; 129: 144-154.
83. Way WL, Costley EC, Way EL. Respiratory sensitivity of the newborn infant to meperidine and morphine. Clinical Pharmacology and Therapeutics 1965; 6: 454-461.
84. Woolf CJ. Somatic pain - pathogenesis and prevention. British Journal of Anaesthesia 1995; 75: 169-176.
85. Yaksh TL, Al-Rodhan NRF, Jensen TS. Sites of action of opiates in production of analgesia. In: Fields HL, Besson JM, eds. Progress in Brain Research. Amsterdam: Elsevier, 1988; 371-394.
86. Zadina JE, Kastin AJ. Neonatal peptides affect developing rats: β-endorphin alters nociception and opiate receptors, corticotrophin-releasing factor alters corticosterone. Developmental Brain Research 1986; 29: 21-29.